News from the I-BFM Study Group


The International BFM Study Group (Leukemias and Lymphomas) is excited to invite you to an upcoming event organized by, Arndt Borkhardt, Merja Heinäniemi and Anindita Roy: the EMBO workshop titled “Intercepting Childhood Blood Cancer: From Single Cells To Malignant Clones”.

The goal of this EMBO workshop is to accelerate the understanding of tumor evolution, its mutability, plasticity, and adaptation at the single cell level in order to promote new prevention approaches and precision medicine for blood cancer.

Innovative cutting-edge techniques ranging from single-cell omics, artificial intelligence and computational modeling to realistic 3D culture systems and in vivo models will be discussed with young scientists, clinicians and leading experts to advance research and adapt to clinical needs. This EMBO workshop provides an ideal environment for interdisciplinary networking among participants, exchange of scientific knowledge and ideas, and will foster exciting new collaborations.

The event will be held from 3-6 May 2024, at Design Offices Düsseldorf Fürst & Friedrich, conveniently situated next to the Old City of Düsseldorf. If you would like to learn more about the great line-up of this EBMO workshop or register, we invite you to visit the event website.

We invite you to attend this event to stay abreast of the latest advances in clinical trial design and implementation. Your participation will help us ensure that our clinical trials are conducted in a rigorous and efficient manner and that our research results are of the highest quality.

Thank you for your continued participation, the I-BFM Clinical Trial Group.